genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2023

Immunization

Optimizing Personalized Cancer Immunotherapy Manufacturing Using Enzymatic DNA
Bioprocessing

Optimizing Personalized Cancer Immunotherapy Manufacturing Using Enzymatic DNA

Potential Target for Autoimmune Diseases Discovered
News

Potential Target for Autoimmune Diseases Discovered

A Vaccination Strategy against Diarrhea-Causing Pathogens
Featured

A Vaccination Strategy against Diarrhea-Causing Pathogens

Chaperones That Optimize Immune Presentation of Antigens Identified
News

Chaperones That Optimize Immune Presentation of Antigens Identified

GSK to Acquire Affinivax for Up to $3.3B, Bolstering Vaccine Portfolio
Drug Discovery

GSK to Acquire Affinivax for Up to $3.3B, Bolstering Vaccine Portfolio

Delayed Adaptive Immune Response to Tuberculosis Points to Vaccination Strategies
Drug Discovery

Delayed Adaptive Immune Response to Tuberculosis Points to Vaccination Strategies

Cancer Therapy Search Gets Boost from NIH Grant
Cancer

Cancer Therapy Search Gets Boost from NIH Grant

Studies Suggest Noradrenaline Represents Mechanistic Link between Stress and Weakened Immunity
News

Studies Suggest Noradrenaline Represents Mechanistic Link between Stress and Weakened Immunity

J&J Reports 66% Overall Efficacy for One-Dose COVID-19 Vaccine
Coronavirus

J&J Reports 66% Overall Efficacy for One-Dose COVID-19 Vaccine

Novavax Reports Varying Success vs. COVID-19 Variants
Coronavirus

Novavax Reports Varying Success vs. COVID-19 Variants

123...9Page 1 of 9

Read the Digital Edition

August 2023 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up